A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting

Clinical trial NCT02493777 · COMPLETED

Trial details

NCT number: NCT02493777
Sponsor: Ironshore Pharmaceuticals and Development, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2015-07-01
Primary completion: 2016-02-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.